Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart

F G Spinale1, M L Coker, C V Thomas

  • 1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston 29425, USA.

Circulation Research
|March 20, 1998
PubMed

Insights

Matrix metalloproteinases (MMPs) show early changes in activity during congestive heart failure (CHF) development. This suggests MMPs contribute to left ventricular (LV) remodeling and dysfunction in early-stage CHF.

Area of Science:

  • Cardiovascular Biology
  • Biochemistry
  • Pathology

Background:

  • Congestive heart failure (CHF) involves left ventricular (LV) dilation and myocardial remodeling.
  • The precise mechanisms driving this remodeling during CHF progression are not fully understood.
  • Matrix metalloproteinases (MMPs) are implicated in tissue remodeling across various pathological conditions.

Purpose of the Study:

  • To investigate the hypothesis that LV dilation and remodeling in CHF progression are linked to early alterations in MMP expression and activity.
  • To examine the temporal relationship between MMP changes and the development of LV dysfunction and remodeling.

Main Methods:

  • Pigs underwent pacing-induced supraventricular tachycardia (SVT) to model CHF.
  • Serial measurements of LV and myocyte function, collagen content, and MMP expression/activity were performed.
  • Specific MMPs (MMP-1, MMP-3, MMP-2) and overall MMP zymographic activity were assessed.

Main Results:

  • SVT induced progressive LV dilation and myocyte dysfunction, leading to CHF symptoms.
  • Early LV remodeling (7 days) showed decreased collagen content and an 80% increase in MMP activity.
  • MMP-1, MMP-3, and MMP-2 levels approximately doubled after 7 days of SVT, with sustained elevations.

Conclusions:

  • Early increases in LV myocardial MMP zymographic activity and protein levels coincide with the onset and progression of LV dilation and dysfunction in this CHF model.
  • Enhanced MMP expression and activity are suggested as early contributors to LV remodeling in developing CHF.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...